Anlon Healthcare Limited has informed the Exchange that the Board of Directors at its meeting held on March 06, 2026, has considered and approved 1. Sub-division of equity shares from face value of Rs.10/- each to face value of Rs.02/- each., 2. Alteration of Capital Clause of the Memorandum of Association of the Company Subsequent to Sub-Division of Equity Shares, 3. Increase in Authorized Share Capital and Consequent Alteration to the Capital Clause of the Memorandum of Association, 4. Issue of Bonus Shares in the ratio of 1:1.